{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:56:23Z","timestamp":1777474583403,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jceh.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T19:13:00Z","timestamp":1616785980000},"page":"110-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnosis of Primary Sclerosing Cholangitis Beyond Childhood is Associated with Worse Outcomes"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6935-9746","authenticated-orcid":false,"given":"Stefani","family":"Tica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Tait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonsa","family":"Nemera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumirle","family":"Turmelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaquelyn","family":"Fleckenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janis","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakil","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.03.006_bib1","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2021.03.006_bib2","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.03.006_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.03.006_bib4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.21405","article-title":"Sclerosing cholangitis: a focus on secondary causes","volume":"44","author":"Abdalian","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.03.006_bib5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.03.006_bib6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.03.006_bib7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.03.006_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.27191","volume":"60","author":"Squires","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.03.006_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-3476(94)70253-5","article-title":"Sclerosing cholangitis in children","volume":"124","author":"Debray","year":"1994","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jceh.2021.03.006_bib10","first-page":"1415","article-title":"Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis","volume":"22","author":"Wilschanski","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.03.006_bib11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.03.006_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.03.006_bib13","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient Age, sex, and inflammatory bowel disease phenotype Associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.03.006_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cld.2015.08.008","article-title":"Sclerosing cholangitis in children and adolescents","volume":"20","author":"Mieli-Vergani","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2021.03.006_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/hep.29208","article-title":"The riddle of juvenile sclerosing cholangitis","volume":"66","author":"Mieli-Vergani","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.03.006_bib16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/17474124.2018.1521719","article-title":"Primary sclerosing cholangitis in children versus adults: lessons for the clinic","volume":"12","author":"Adike","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.03.006_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MOG.0000000000000352","article-title":"Emerging pharmacologic therapies for primary sclerosing cholangitis","volume":"33","author":"Cheung","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jceh.2021.03.006_bib18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/jhep.2002.31872","article-title":"Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis","volume":"35","author":"Boberg","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.03.006_bib19","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jhep.2019.06.012","article-title":"Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis","volume":"71","author":"Goet","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.03.006_bib20","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/hep.30479","article-title":"Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system","volume":"69","author":"Goode","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.03.006_bib21","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.03.006_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/2050640617717156","article-title":"Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis","volume":"6","author":"Rupp","year":"2018","journal-title":"Unit Eur Gastroenterol J"},{"key":"10.1016\/j.jceh.2021.03.006_bib23","first-page":"251730","article-title":"How does age at onset influence the outcome of autoimmune diseases?","volume":"2012","author":"Amador-Patarroyo","year":"2012","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.jceh.2021.03.006_bib24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM200102083440604","article-title":"Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct","volume":"344","author":"Hammel","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.03.006_bib25","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/gutjnl-2016-313681","article-title":"A\u00a0novel prognostic model for transplant-free survival in primary sclerosing cholangitis","volume":"67","author":"de Vries","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.03.006_bib26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A\u00a0revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jceh.2021.03.006_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2019.01.039","article-title":"Ursodeoxycholic acid therapy in pediatric primary sclerosing cholangitis: predictors of gamma glutamyltransferase normalization and favorable clinical course","volume":"209","author":"Deneau","year":"2019","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jceh.2021.03.006_bib28","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep4.1251","article-title":"Gamma glutamyltransferase reduction is associated with favorable outcomes in pediatric primary sclerosing cholangitis","volume":"2","author":"Deneau","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2021.03.006_bib29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1183\/09031936.00136408","article-title":"Small studies: strengths and limitations","volume":"32","author":"Hackshaw","year":"2008","journal-title":"Eur Respir J"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368832100058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368832100058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:06:44Z","timestamp":1760854004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S097368832100058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S097368832100058X"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.03.006","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of Primary Sclerosing Cholangitis Beyond Childhood is Associated with Worse Outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}